Brainchip Holdings Limited (BRN) is the first-to-market neuromorphic processor, Akida, mimics the human brain to analyse only essential sensor inputs at the point of acquisition, processing data with unparalleled efficiency, precision, and economy of energy. Keeping machine learning local to the chip, independent of the cloud, also dramatically reduces latency while improving privacy and data security.
Find out what a historical investment in BrainChip Holdings would be worth today using our BRN stock calculator.
Buying BRN shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in BrainChip Holdings in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in BRN
What is the ticker symbol of BrainChip Holdings?
The ticker symbol for BrainChip Holdings is BRN.
How much is one share of BRN?
One share of BRN is valued at $0.09 as of 22 November 2026.
What is the market capitalisation of BrainChip Holdings BRN?
As of 22 November 2026 BrainChip Holdings has a market cap of $207.11M.
What is the P/E ratio of BRN?
The Price to Earnings ratio of BRN is -6.85.
What is the Earnings Per Share of BRN?
The Earnings Per Share of BRN is -$0.01.
What is the 52-week high for BrainChip Holdings stock?
The BrainChip Holdings 52-week high stock price is $0.21.
What is the 52-week low for BrainChip Holdings stock?
The BrainChip Holdings 52-week low stock price is $0.09.
Can I buy BRN shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy BRN shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.